• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Exercise behavior, practice, injury, and symptoms of respiratory tract infection of 502 Brazilian adults during lockdown oscillations in two years (2021 –2022) of the COVID-19 pandemic
ConclusionAfter two years of the COVID-19 pandemic (2021 –2022), with periods of lockdown, there were low reports of injuries and pain symptoms after exercising on the return to physical exercise practices of running and strength training. However, the restrictions negatively affected the exercise behavior due to respiratory tract symptoms of COVID-19 a nd a reduction in training intensity, performed without any professional or technical supervision. The participants reported the use of a fabric or surgical mask for the prevention of COVID-19, and an increased feeling of anxiety. The reasons given for practicing physical...
Source: BMC Sports Science, Medicine and Rehabilitation - August 1, 2023 Category: Sports Medicine Source Type: research

Acute exacerbation of idiopathic hypereosinophilic syndrome following asymptomatic coronavirus disease 2019: a case report
ConclusionAlthough the relationship between asymptomatic coronavirus disease 2019 and acute idiopathic hypereosinophilic syndrome exacerbation was uncertain, the chronological order of the symptomatic development suggested a possible link. More clinical cases and population-based studies are needed to determine the potential effect of coronavirus disease 2019 on autoimmune diseases.
Source: Journal of Medical Case Reports - August 31, 2022 Category: General Medicine Source Type: research

Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?
CONCLUSION: The incidence of coronavirus disease 2019 infection in patients with inflammatory bowel disease was not different from the general population during the severe acute respiratory syndrome coronavirus 2 pandemic. Coronavirus disease 2019 infection does not progress with poor prognosis in patients with inflammatory bowel disease who receive immunosuppressive therapy including biological agents.PMID:35410854 | DOI:10.5152/tjg.2022.211113
Source: The Turkish Journal of Gastroenterology - April 12, 2022 Category: Gastroenterology Authors: Bilger Çavuş Filiz Aky üz Asl ı Örmeci Çifçibaşı İlker Özgür Cansu Erel Aysun Yakut Ziya İmanov İbrahim Volkan Şenkal Alpay Medetalibeyo ğlu Murat K öse Metin Keskin Kadir Demir Fatih Be şışık Sabahattin Kaymako ğlu Source Type: research

Pages: 1  2  3  4